Inflammation happens as the protective response of the body against pain, or factors that possibly damage it, such as toxins, injuries or infections. Think of it as the attempt of our body to heal and protect itself. Inflammation comes in two types: chronic and acute. The former is the prolonged inflammatory response of the body, and the issue is potentially harmful to its tissues and organs. The latter inflammation usually follows an injury, infection, or illness. In that case, our immune system will release cells to the affected part of the body as protection, which brings about redness and swelling.
Chronic inflammation comes with tuberculosis, asthma and other long-term health conditions. While inflammation may play a big part in healing, its chronic type puts you at more risk of developing conditions such as periodontitis, arthritis or even some kinds of cancer. Research suggests that cannabidiol could work as a treatment option for the inflammation that comes in different diseases. While featured studies on cannabidiol for inflammation are promising, existing clinical trials are not deemed conclusive. That is to say, more rigorous trials are required.
How Cannabidiol Might Lessen It
Furthermore, almost every study about CBD and inflammation is performed on animals. Doing clinical trials with human beings would necessitate further studies. Nevertheless, past animal trials showed promising outputs, particularly about cannabidiol’s anti-inflammatory effects.
In the trials, it was demonstrated that cannabidiol could interact with the animals’ immune system, thus lessening the inflammation and pain in various conditions.
Cannabidiol can hinder an enzyme that helps the body to create inflammation, which is among the ways it can drive down the issue. There are other treatment options that function by targeting the said enzyme. Further, cannabidiol may act on the endocannabinoid system, thereby affecting inflammation. The ECS is a biological system essential for ensuring that the nervous system and immune system are in their optimum conditions.
Cannabidiol appears to impact anandamide, too, an enzyme that must regulate inflammation. The phytocannabinoid may also bring down cytokines, which are proteins in the human immune system that play a part in producing inflammation. The above-mentioned properties of cannabidiol may contribute to less inflammation.
It appears that cannabidiol’s anti-inflammatory effects are through the receptors that form the ECS. Known as cannabinoid receptors, they become active as an inflammatory response, and are part of the said biological system.